These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 15816794)

  • 1. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizophrenia, diabetes mellitus and antipsychotics].
    Gury C
    Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.
    Ramaswamy K; Masand PS; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.
    Citrome L; Kalsekar I; Baker RA; Hebden T
    Curr Med Res Opin; 2014 Aug; 30(8):1629-41. PubMed ID: 24666104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
    Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S
    J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia.
    Ader M; Garvey WT; Phillips LS; Nemeroff CB; Gharabawi G; Mahmoud R; Greenspan A; Berry SA; Musselman DL; Morein J; Zhu Y; Mao L; Bergman RN
    J Psychiatr Res; 2008 Oct; 42(13):1076-85. PubMed ID: 18295798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.
    Wang CJ; Zhang ZJ; Sun J; Zhang XB; Mou XD; Zhang XR; Shang XF; Zhang TQ
    Biol Psychiatry; 2006 Dec; 60(12):1309-13. PubMed ID: 16650386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal glucose metabolism in patients treated with antipsychotics.
    Scheen AJ; De Hert MA
    Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic studies of atypical antipsychotic agents and diabetes.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):72-9. PubMed ID: 19667654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
    Guina J; Roy S; Gupta A; Langleben DD; Elman I
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28573760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics and diabetes mellitus.
    Lichiardopol R
    Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
    Melkersson K; Berinder K; Hulting AL
    Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study.
    Mackin P; Watkinson HM; Young AH
    Diabetologia; 2005 Feb; 48(2):215-21. PubMed ID: 15688206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.